Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pivot Pharmaceuticals Inc (PVOTF)

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 21,701
  • Shares Outstanding, K 171,414
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,780 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PVOTF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/15/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +94.77%
on 06/05/20
0.2588 -51.08%
on 05/18/20
-0.0487 (-27.78%)
since 05/08/20
3-Month
0.0301 +320.60%
on 03/23/20
0.2588 -51.08%
on 05/18/20
+0.0566 (+80.86%)
since 03/06/20
52-Week
0.0301 +320.60%
on 03/23/20
0.3800 -66.68%
on 07/15/19
-0.1956 (-60.71%)
since 06/07/19

Most Recent Stories

More News
BetterLife Pharma Announces Consolidation of its Common Shares

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: BETRF) (FRA: NPAT) announces that it has consolidated its common shares on the basis of one new common share...

PVOTF : 0.1266 (-4.74%)
BETR.CN : 0.295 (-4.84%)
BETRF : 0.2400 (-6.54%)
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: PVOTF) (FSE: NPAT) is pleased to provide an update to its press release of whereby BetterLife announced...

BETR.CN : 0.295 (-4.84%)
PVOTF : 0.1266 (-4.74%)
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum

,

PVOTF : 0.1266 (-4.74%)
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board

, /PRNewswire/ -BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. to the Company's Scientific Advisory Board. Dr....

PVOTF : 0.1266 (-4.74%)
BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that the journal Frontiers of Immunology ("") released the results of the...

PVOTF : 0.1266 (-4.74%)
BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that a third party study is scheduled to be released this Friday in the journal...

PVOTF : 0.1266 (-4.74%)
Pivot Pharmaceuticals re-brands as BetterLife Pharma Inc

Pivot Pharmaceuticals Inc. today announced its corporate name change to BetterLife Pharma Inc. The Company will change its ticker symbol to BETR. taking effect immediately. BetterLife is committed to becoming...

PVOTF : 0.1266 (-4.74%)
Pivot Pharma Launches Canadian Cannabis and Nutraceutical Manufacturing Facility

Health Canada licensing documentation in preparation; production to start in next 90 days

CCAN : 0.0360 (-10.00%)
PVOTF : 0.1266 (-4.74%)
Pivot Pharma enters US CBD market with its proprietary CBD product line

Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture Pivot's differentiated portfolio of CBD...

PVOTF : 0.1266 (-4.74%)
PIVOT responds to Stockwatch Article on Notice of Claim filed by Aly Ismail

Pivot Pharmaceuticals Inc. (CSE: PVOT /OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company"), is responding to the Stockwatch Article dated September 18, 2019 regarding the claims filed by Aly Ismail/Green...

PVOTF : 0.1266 (-4.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.1529
1st Resistance Point 0.1397
Last Price 0.1266
1st Support Level 0.1067
2nd Support Level 0.0869
3rd Support Level N/A

See More

52-Week High 0.3800
Fibonacci 61.8% 0.2463
Fibonacci 50% 0.2050
Fibonacci 38.2% 0.1638
Last Price 0.1266
52-Week Low 0.0301

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar